As per fund houses, a large number of mutual fund folios do not have nominations, though the exact number is unknown. Nomination was not compulsory earlier in demat accounts and mutual funds and this led to many investors skipping these details.
Biocon shares rise 2% on 10-year Pertuzumab supply deal for breast cancer therapy in Brazil
Biocon shares rose after the company secured a 10-year Pertuzumab supply contract in Brazil. The consortium with Bahiafarma and Bionovis received full allocation under the